Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1976 Jan;73(1):203-7.
doi: 10.1073/pnas.73.1.203.

Reiteration frequency of immunoglobulin light chain genes: further evidence for somatic generation of antibody diversity

Reiteration frequency of immunoglobulin light chain genes: further evidence for somatic generation of antibody diversity

S Tonegawa. Proc Natl Acad Sci U S A. 1976 Jan.

Abstract

Methods have been developed for preparing mouse immunoglobulin light chain mRNA of better than 90% purity. Hybridization of both lambda and kappa mRNAs to excess liver DNA yielded results compatible with gene reiteration frequencies of two to three. There was no evidence of hybridization of these highly purified mRNAs to reiterated DNA, and, in fact, the kinetics of hybridization were very similar to that of purified globin mRNA. Purified lambda mRNA from tumors producing structurally different lambda chains were used in competition hybridization experiments. An unlabeled lambda mRNA competed with another, labeled lambda mRNA to the same extent as homologous unlabeled lambda mRNA. That is, base sequence homology among lambda mRNAs is so high that any lambda mRNA should cross-hybridize with all germ line variable (Vlambda) genes at least for those V-regions which are represented among myelomas. From amino-acid sequence data, it is argued that there are probably more than 25 different lambda V regions. Hence it is concluded that the number of germ line genes is too small to account for the diversity of lambda chains. A similar conclusion is drawn for kappa chains.

PubMed Disclaimer

References

    1. Nat New Biol. 1973 Aug 22;244(138):236-40 - PubMed
    1. Scand J Immunol. 1973;2(3):199-206 - PubMed
    1. FEBS Lett. 1974 Jun 15;42(3):323-6 - PubMed
    1. Proc Natl Acad Sci U S A. 1974 Sep;71(9):3659-63 - PubMed
    1. Proc Natl Acad Sci U S A. 1974 Oct;71(10):4027-31 - PubMed

MeSH terms

Substances

LinkOut - more resources